SGLT2 inhibitors may decrease risk of cardiac events in patients treated with anthracyclines - Medical Dialogues
6/15/2022 12:00:00 AM2 years 10 months ago
by Jacinthlyn Sylvia
by Jacinthlyn Sylvia
USA: A new study published in the Journal of American College of Cardiology suggests that...
USA: A new study published in the Journal of American College of Cardiology suggests that sodium-glucose co-transporter-2 (SGLT2) inhibitors were related to a decreased risk of cardiac events in indi… [+2359 chars]
full article...